NCT07053930View on ClinicalTrials.gov

Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Labor

Interventions

DRUG

Intraumbilical oxytocin

Patients were given 10 U of intraumbilical oxytocin, diluted in 10 mL of normal saline.

DRUG

Intravenous oxytocin

Patients received 20 U of intravenous oxytocin diluted in 500 mL of normal saline.

Trial Locations (1)

63100

Sadiq Abbasi Hospital, Bahawalpur

All Listed Sponsors

lead

RESnTEC, Institute of Research

OTHER

NCT07053930 - Comparison of the Mean Duration of 3rd Stage of Labour Between Intraumbilical and Intravenous Oxytocin | Biotech Hunter | Biotech Hunter